Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04885452
What this trial is testing

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Who this might be right for
SARS-CoV InfectionCovid19
ANRS, Emerging Infectious Diseases 756
Large-scale testing (Phase 3)UnknownNCT04351152
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
Humanigen, Inc. 520
Not applicableUnknownNCT04375176
What this trial is testing

Monocytes and NK Cells Activity in Covid-19 Patients

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome Coronavirus 2Immunomodulation
Università degli Studi dell'Insubria 150
Testing effectiveness (Phase 2)UnknownNCT04457726
What this trial is testing

Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

Who this might be right for
COVID-19
KK Women's and Children's Hospital 18
Large-scale testing (Phase 3)WithdrawnNCT05157269
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Testing effectiveness (Phase 2)Ended earlyNCT04409873
What this trial is testing

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)

Who this might be right for
COVID-19SARS-CoV 2Severe Acute Respiratory Syndrome Coronavirus 2+3 more
University of California, San Francisco 54
Testing effectiveness (Phase 2)UnknownNCT04395456
What this trial is testing

The C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)

Who this might be right for
Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)
Amyndas Pharmaceuticals S.A. 144
Early research (Phase 1)Active Not RecruitingNCT07709637
What this trial is testing

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 1
Early research (Phase 1)UnknownNCT05212532
What this trial is testing

A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress Syndrome
EOM Pharmaceuticals 40
Not applicableStudy completedNCT05092698
What this trial is testing

The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19

Who this might be right for
SARS-CoV2 Infection
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 110
Not applicableUnknownNCT04893668
What this trial is testing

Depression and Anxiety in Long Term Coronavirus Disease COVID-19

Who this might be right for
Covid19DepressionAnxiety
Hasanuddin University 165
Large-scale testing (Phase 3)WithdrawnNCT04452474
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

Who this might be right for
COVID-19
R-Pharm
Large-scale testing (Phase 3)Ended earlyNCT04405271
What this trial is testing

TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)

Who this might be right for
Healthcare WorkersCOVID-19SARS-CoV 2
Hospital Italiano de Buenos Aires 1,378
Testing effectiveness (Phase 2)Study completedNCT04357730
What this trial is testing

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

Who this might be right for
Severe Acute Respiratory SyndromeRespiratory FailureAcute Respiratory Distress Syndrome
Denver Health and Hospital Authority 50
Not applicableUnknownNCT04367129
What this trial is testing

Electrocardiogram Analysis in COVID-19 Patients

Who this might be right for
SARS-CoV Infection
University Hospital of Ferrara 1,014
Not applicableStudy completedNCT06423560
What this trial is testing

Pulmonary Fibrosis After Severe COVID-19 Pneumonia

Who this might be right for
Pulmonary FibrosisCOVID-19
IRCCS San Raffaele 61
Not applicableEnded earlyNCT04930874
What this trial is testing

Cerebral Autoregulation and COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCOVID-19 Pneumonia
University of Athens 7
Testing effectiveness (Phase 2)Study completedNCT04342650
What this trial is testing

Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection

Who this might be right for
COVID-19SARS-CoV InfectionSevere Acute Respiratory Syndrome (SARS) Pneumonia+1 more
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 152
Large-scale testing (Phase 3)UnknownNCT04891172
What this trial is testing

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Who this might be right for
Covid19
Dow University of Health Sciences 310
Not applicableStudy completedNCT05196477
What this trial is testing

Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection

Who this might be right for
COVID-19
R-Pharm 3,087
Next Page